{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:59:14Z","timestamp":1787317154086,"version":"build-2736575974"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170119"],"award-info":[{"award-number":["82170119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Jiangsu Province","award":["202310285172Y"],"award-info":[{"award-number":["202310285172Y"]}]},{"name":"the National Key Research and Development Program of China","award":["2022YFC2502700\uff0c2022YFC2502701\uff0c2022YFC2502702"],"award-info":[{"award-number":["2022YFC2502700\uff0c2022YFC2502701\uff0c2022YFC2502702"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Base editors, developed from the CRISPR\/Cas system, consist of components such as deaminase and Cas variants. Since their emergence in 2016, the precision, efficiency, and safety of base editors have been gradually optimized. The feasibility of using base editors in gene therapy has been demonstrated in several disease models. Compared with the CRISPR\/Cas system, base editors have shown great potential in hematopoietic stem cells (HSCs) and HSC-based gene therapy, because they do not generate double-stranded breaks (DSBs) while achieving the precise realization of single-base substitutions. This precise editing mechanism allows for the permanent correction of genetic defects directly at their source within HSCs, thus promising a lasting therapeutic effect. Recent advances in base editors are expected to significantly increase the number of clinical trials for HSC-based gene therapies. In this review, we summarize the development and recent progress of DNA base editors, discuss their applications in HSC gene therapy, and highlight the prospects and challenges of future clinical stem cell therapies.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s12015-024-10715-5","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T23:09:15Z","timestamp":1713740955000},"page":"1387-1405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases"],"prefix":"10.1007","volume":"20","author":[{"given":"Chengpeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7573-4813","authenticated-orcid":false,"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"issue":"17","key":"10715_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan, E. A. (2006). Hematopoietic stem-cell transplantation. The New England Journal of Medicine, 354(17), 1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMra052638","journal-title":"The New England Journal of Medicine"},{"issue":"19","key":"10715_CR2","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","volume":"121","author":"JJ Boelens","year":"2013","unstructured":"Boelens, J. J., Aldenhoven, M., Purtill, D., Ruggeri, A., Defor, T., Wynn, R., Wraith, E., Cavazzana-Calvo, M., Rovelli, A., Fischer, A., Tolar, J., Prasad, V. K., Escolar, M., Gluckman, E., O\u2019Meara, A., Orchard, P. J., Veys, P., Eapen, M., Kurtzberg, J., \u2026 Eurocord, Blood, I. E. W. P. o. E., Marrow Transplant Group, Duke University Blood and Marrow Transplantation Program, Blood, C. f. I., & Marrow Research. (2013). Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood, 121(19), 3981\u20133987. https:\/\/doi.org\/10.1182\/blood-2012-09-455238","journal-title":"Blood"},{"issue":"2","key":"10715_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","volume":"23","author":"KR Cooke","year":"2017","unstructured":"Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., Van Den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., Martin, P. J., Paczesny, S., Vogelsang, G., Pavletic, S., Ritz, J., Schultz, K. R., & Blazar, B. R. (2017). The biology of chronic graft-versus-host disease: A task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 23(2), 211\u2013234. https:\/\/doi.org\/10.1016\/j.bbmt.2016.09.023","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"8","key":"10715_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/d41573-022-00124-z","volume":"21","author":"K Kingwell","year":"2022","unstructured":"Kingwell, K. (2022). Base editors hit the clinic. Nature Reviews Drug Discovery, 21(8), 545\u2013547. https:\/\/doi.org\/10.1038\/d41573-022-00124-z","journal-title":"Nature Reviews Drug Discovery"},{"issue":"3","key":"10715_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"ML Maeder","year":"2016","unstructured":"Maeder, M. L., & Gersbach, C. A. (2016). Genome-editing technologies for gene and cell therapy. Molecular Therapy, 24(3), 430\u2013446. https:\/\/doi.org\/10.1038\/mt.2016.10","journal-title":"Molecular Therapy"},{"issue":"6096","key":"10715_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816\u2013821. https:\/\/doi.org\/10.1126\/science.1225829","journal-title":"Science"},{"issue":"18","key":"10715_CR7","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1093\/emboj\/17.18.5497","volume":"17","author":"M Takata","year":"1998","unstructured":"Takata, M., Sasaki, M. S., Sonoda, E., Morrison, C., Hashimoto, M., Utsumi, H., Yamaguchi-Iwai, Y., Shinohara, A., & Takeda, S. (1998). Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. The EMBO Journal, 17(18), 5497\u20135508. https:\/\/doi.org\/10.1093\/emboj\/17.18.5497","journal-title":"The EMBO Journal"},{"issue":"2","key":"10715_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DB Cox","year":"2015","unstructured":"Cox, D. B., Platt, R. J., & Zhang, F. (2015). Therapeutic genome editing: Prospects and challenges. Nature Medicine, 21(2), 121\u2013131. https:\/\/doi.org\/10.1038\/nm.3793","journal-title":"Nature Medicine"},{"issue":"4","key":"10715_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman, J. R., Taylor, M. R., & Boulton, S. J. (2012). Playing the end game: DNA double-strand break repair pathway choice. Molecular Cell, 47(4), 497\u2013510. https:\/\/doi.org\/10.1016\/j.molcel.2012.07.029","journal-title":"Molecular Cell"},{"issue":"7603","key":"10715_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533(7603), 420\u2013424. https:\/\/doi.org\/10.1038\/nature17946","journal-title":"Nature"},{"issue":"7681","key":"10715_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017). Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature, 551(7681), 464\u2013471. https:\/\/doi.org\/10.1038\/nature24644","journal-title":"Nature"},{"issue":"1","key":"10715_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41587-020-0592-2","volume":"39","author":"D Zhao","year":"2021","unstructured":"Zhao, D., Li, J., Li, S., Xin, X., Hu, M., Price, M. A., Rosser, S. J., Bi, C., & Zhang, X. (2021). Glycosylase base editors enable C-to-A and C-to-G base changes. Nature Biotechnology, 39(1), 35\u201340. https:\/\/doi.org\/10.1038\/s41587-020-0592-2","journal-title":"Nature Biotechnology"},{"issue":"8","key":"10715_CR13","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","volume":"41","author":"H Tong","year":"2023","unstructured":"Tong, H., Wang, X., Liu, Y., Liu, N., Li, Y., Luo, J., Ma, Q., Wu, D., Li, J., Xu, C., & Yang, H. (2023). Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase. Nature Biotechnology, 41(8), 1080\u20131084. https:\/\/doi.org\/10.1038\/s41587-022-01595-6","journal-title":"Nature Biotechnology"},{"issue":"7785","key":"10715_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., & Liu, D. R. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576(7785), 149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4","journal-title":"Nature"},{"issue":"3","key":"10715_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen, P. J., & Liu, D. R. (2023). Prime editing for precise and highly versatile genome manipulation. Nature Reviews Genetics, 24(3), 161\u2013177. https:\/\/doi.org\/10.1038\/s41576-022-00541-1","journal-title":"Nature Reviews Genetics"},{"issue":"7320","key":"10715_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature09523","volume":"468","author":"JE Garneau","year":"2010","unstructured":"Garneau, J. E., Dupuis, M. E., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadan, A. H., & Moineau, S. (2010). The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468(7320), 67\u201371. https:\/\/doi.org\/10.1038\/nature09523","journal-title":"Nature"},{"issue":"7340","key":"10715_CR17","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 471(7340), 602\u2013607. https:\/\/doi.org\/10.1038\/nature09886","journal-title":"Nature"},{"issue":"7490","key":"10715_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature13011","volume":"507","author":"SH Sternberg","year":"2014","unstructured":"Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014). DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 507(7490), 62\u201367. https:\/\/doi.org\/10.1038\/nature13011","journal-title":"Nature"},{"issue":"3","key":"10715_CR19","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., Van Der Oost, J., Regev, A., Koonin, E. V., & Zhang, F. (2015). Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell, 163(3), 759\u2013771. https:\/\/doi.org\/10.1016\/j.cell.2015.09.038","journal-title":"Cell"},{"issue":"2","key":"10715_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","volume":"18","author":"KS Makarova","year":"2020","unstructured":"Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S. A., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D., Haft, D. H., Horvath, P., Moineau, S., Mojica, F. J. M., Scott, D., Shah, S. A., Siksnys, V., Terns, M. P., Venclovas, \u010c, White, M. F., Yakunin, A. F., \u2026 Koonin, E. V. (2020). Evolutionary classification of CRISPR\u2013Cas systems: A burst of class 2 and derived variants. Nature Reviews Microbiology, 18(2), 67\u201383. https:\/\/doi.org\/10.1038\/s41579-019-0299-x","journal-title":"Nature Reviews Microbiology"},{"issue":"6121","key":"10715_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F. (2013). Multiplex genome engineering using CRISPR\/Cas systems. Science, 339(6121), 819\u2013823. https:\/\/doi.org\/10.1126\/science.1231143","journal-title":"Science"},{"key":"10715_CR22","doi-asserted-by":"publisher","first-page":"17018","DOI":"10.1038\/celldisc.2017.18","volume":"3","author":"X Zhang","year":"2017","unstructured":"Zhang, X., Wang, J., Cheng, Q., Zheng, X., Zhao, G., & Wang, J. (2017). Multiplex gene regulation by CRISPR-ddCpf1. Cell Discovery, 3, 17018. https:\/\/doi.org\/10.1038\/celldisc.2017.18","journal-title":"Cell Discovery"},{"issue":"1","key":"10715_CR23","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/s41467-017-02265-x","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu, Y., Han, J., Chen, Z., Wu, H., Dong, H., & Nie, G. (2017). Engineering cell signaling using tunable CRISPR-Cpf1-based transcription factors. Nature Communications, 8(1), 2095. https:\/\/doi.org\/10.1038\/s41467-017-02265-x","journal-title":"Nature Communications"},{"issue":"8","key":"10715_CR24","doi-asserted-by":"publisher","first-page":"eaao4774","DOI":"10.1126\/sciadv.aao4774","volume":"3","author":"AC Komor","year":"2017","unstructured":"Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017). Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T: A base editors with higher efficiency and product purity. Science Advances, 3(8), eaao4774. https:\/\/doi.org\/10.1126\/sciadv.aao4774","journal-title":"Science Advances"},{"issue":"12","key":"10715_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M., & Yeo, G. W. (2020). Base editing: Advances and therapeutic opportunities. Nature Reviews Drug Discovery, 19(12), 839\u2013859. https:\/\/doi.org\/10.1038\/s41573-020-0084-6","journal-title":"Nature Reviews Drug Discovery"},{"issue":"12","key":"10715_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A., & Liu, D. R. (2018). Base editing: Precision chemistry on the genome and transcriptome of living cells. Nature Reviews Genetics, 19(12), 770\u2013788. https:\/\/doi.org\/10.1038\/s41576-018-0059-1","journal-title":"Nature Reviews Genetics"},{"issue":"5","key":"10715_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41587-022-01532-7","volume":"41","author":"L Chen","year":"2023","unstructured":"Chen, L., Zhu, B., Ru, G., Meng, H., Yan, Y., Hong, M., Zhang, D., Luan, C., Zhang, S., Wu, H., Gao, H., Bai, S., Li, C., Ding, R., Xue, N., Lei, Z., Chen, Y., Guan, Y., Siwko, S., \u2026 Li, D. (2023). Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing. Nature Biotechnology, 41(5), 663\u2013672. https:\/\/doi.org\/10.1038\/s41587-022-01532-7","journal-title":"Nature Biotechnology"},{"issue":"5","key":"10715_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","volume":"41","author":"ME Neugebauer","year":"2023","unstructured":"Neugebauer, M. E., Hsu, A., Arbab, M., Krasnow, N. A., McElroy, A. N., Pandey, S., Doman, J. L., Huang, T. P., Raguram, A., Banskota, S., Newby, G. A., Tolar, J., Osborn, M. J., & Liu, D. R. (2023). Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nature Biotechnology, 41(5), 673\u2013685. https:\/\/doi.org\/10.1038\/s41587-022-01533-6","journal-title":"Nature Biotechnology"},{"issue":"15","key":"10715_CR29","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1016\/j.cell.2023.05.041","volume":"186","author":"J Huang","year":"2023","unstructured":"Huang, J., Lin, Q., Fei, H., He, Z., Xu, H., Li, Y., Qu, K., Han, P., Gao, Q., Li, B., Liu, G., Zhang, L., Hu, J., Zhang, R., Zuo, E., Luo, Y., Ran, Y., Qiu, J. L., Zhao, K. T., & Gao, C. (2023). Discovery of deaminase functions by structure-based protein clustering. Cell, 186(15), 3182-3195 e14. https:\/\/doi.org\/10.1016\/j.cell.2023.05.041","journal-title":"Cell"},{"issue":"7546","key":"10715_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., Koonin, E. V., Sharp, P. A., & Zhang, F. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature, 520(7546), 186\u2013191. https:\/\/doi.org\/10.1038\/nature14299","journal-title":"Nature"},{"issue":"4","key":"10715_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.molcel.2018.12.003","volume":"73","author":"A Edraki","year":"2019","unstructured":"Edraki, A., Mir, A., Ibraheim, R., Gainetdinov, I., Yoon, Y., Song, C. Q., Cao, Y., Gallant, J., Xue, W., Rivera-Perez, J. A., & Sontheimer, E. J. (2019). A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing. Molecular Cell, 73(4), 714-726 e4. https:\/\/doi.org\/10.1016\/j.molcel.2018.12.003","journal-title":"Molecular Cell"},{"issue":"7","key":"10715_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., Doudna, J. A., & Liu, D. R. (2020). Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nature Biotechnology, 38(7), 883\u2013891. https:\/\/doi.org\/10.1038\/s41587-020-0453-z","journal-title":"Nature Biotechnology"},{"issue":"4","key":"10715_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.3803","volume":"35","author":"YB Kim","year":"2017","unstructured":"Kim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017). Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nature Biotechnology, 35(4), 371\u2013376. https:\/\/doi.org\/10.1038\/nbt.3803","journal-title":"Nature Biotechnology"},{"issue":"7699","key":"10715_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., Zeina, C. M., Gao, X., Rees, H. A., Lin, Z., & Liu, D. R. (2018). Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 556(7699), 57\u201363. https:\/\/doi.org\/10.1038\/nature26155","journal-title":"Nature"},{"issue":"7561","key":"10715_CR35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Topkar, V. V., Nguyen, N. T., Zheng, Z., Gonzales, A. P., Li, Z., Peterson, R. T., Yeh, J. R., Aryee, M. J., & Joung, J. K. (2015). Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 523(7561), 481\u2013485. https:\/\/doi.org\/10.1038\/nature14592","journal-title":"Nature"},{"issue":"1","key":"10715_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41467-020-20650-x","volume":"12","author":"GW Goldberg","year":"2021","unstructured":"Goldberg, G. W., Spencer, J. M., Giganti, D. O., Camellato, B. R., Agmon, N., Ichikawa, D. M., Boeke, J. D., & Noyes, M. B. (2021). Engineered dual selection for directed evolution of SpCas9 PAM specificity. Nature Communications, 12(1), 349. https:\/\/doi.org\/10.1038\/s41467-020-20650-x","journal-title":"Nature Communications"},{"issue":"Database issue","key":"10715_CR37","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014). ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Research, 42(Database issue), D980\u2013D985. https:\/\/doi.org\/10.1093\/nar\/gkt1113","journal-title":"Nucleic Acids Research"},{"issue":"9","key":"10715_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W., Doman, J. L., Wilson, C., Levy, J. M., Tay, T., Newby, G. A., Maianti, J. P., Raguram, A., & Liu, D. R. (2018). Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nature Biotechnology, 36(9), 843\u2013846. https:\/\/doi.org\/10.1038\/nbt.4172","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10715_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","volume":"39","author":"IC Kurt","year":"2021","unstructured":"Kurt, I. C., Zhou, R., Iyer, S., Garcia, S. P., Miller, B. R., Langner, L. M., Grunewald, J., & Joung, J. K. (2021). CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nature Biotechnology, 39(1), 41\u201346. https:\/\/doi.org\/10.1038\/s41587-020-0609-x","journal-title":"Nature Biotechnology"},{"issue":"18","key":"10715_CR40","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1182\/blood-2018-10-808873","volume":"133","author":"MD Filippi","year":"2019","unstructured":"Filippi, M. D., & Ghaffari, S. (2019). Mitochondria in the maintenance of hematopoietic stem cells: New perspectives and opportunities. Blood, 133(18), 1943\u20131952. https:\/\/doi.org\/10.1182\/blood-2018-10-808873","journal-title":"Blood"},{"key":"10715_CR41","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1038\/ncomms7494","volume":"6","author":"KJ Ahlqvist","year":"2015","unstructured":"Ahlqvist, K. J., Leoncini, S., Pecorelli, A., Wortmann, S. B., Ahola, S., Forsstrom, S., Guerranti, R., De Felice, C., Smeitink, J., Ciccoli, L., Hamalainen, R. H., & Suomalainen, A. (2015). MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction. Nature Communications, 6, 6494. https:\/\/doi.org\/10.1038\/ncomms7494","journal-title":"Nature Communications"},{"key":"10715_CR42","doi-asserted-by":"publisher","unstructured":"Gattermann, N., Retzlaff, S., Wang, Y. L., Hofhaus, G., Heinisch, J., Aul, C., & Schneider, W. (1997). Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood, 90(12), 4961\u20134972. https:\/\/doi.org\/10.1182\/blood.V90.12.4961.4961_4961_4972","DOI":"10.1182\/blood.V90.12.4961.4961_4961_4972"},{"issue":"7817","key":"10715_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","volume":"583","author":"BY Mok","year":"2020","unstructured":"Mok, B. Y., de Moraes, M. H., Zeng, J., Bosch, D. E., Kotrys, A. V., Raguram, A., Hsu, F., Radey, M. C., Peterson, S. B., Mootha, V. K., Mougous, J. D., & Liu, D. R. (2020). A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature, 583(7817), 631\u2013637. https:\/\/doi.org\/10.1038\/s41586-020-2477-4","journal-title":"Nature"},{"issue":"10","key":"10715_CR44","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.cell.2022.03.039","volume":"185","author":"SI Cho","year":"2022","unstructured":"Cho, S. I., Lee, S., Mok, Y. G., Lim, K., Lee, J., Lee, J. M., Chung, E., & Kim, J. S. (2022). Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell, 185(10), 1764-1776 e12. https:\/\/doi.org\/10.1016\/j.cell.2022.03.039","journal-title":"Cell"},{"issue":"17","key":"10715_CR45","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2014-12-570200","volume":"125","author":"CJ Eaves","year":"2015","unstructured":"Eaves, C. J. (2015). Hematopoietic stem cells: Concepts, definitions, and the new reality. Blood, 125(17), 2605\u20132613. https:\/\/doi.org\/10.1182\/blood-2014-12-570200","journal-title":"Blood"},{"issue":"5","key":"10715_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","volume":"21","author":"RA Morgan","year":"2017","unstructured":"Morgan, R. A., Gray, D., Lomova, A., & Kohn, D. B. (2017). Hematopoietic stem cell gene therapy: Progress and lessons learned. Cell Stem Cell, 21(5), 574\u2013590. https:\/\/doi.org\/10.1016\/j.stem.2017.10.010","journal-title":"Cell Stem Cell"},{"key":"10715_CR47","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., & Vichinsky, E. P. (2018). Sickle cell disease. Nature Reviews Disease Primers, 4, 18010. https:\/\/doi.org\/10.1038\/nrdp.2018.10","journal-title":"Nature Reviews Disease Primers"},{"issue":"16","key":"10715_CR48","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017). Sickle cell disease. The New England Journal of Medicine, 376(16), 1561\u20131573. https:\/\/doi.org\/10.1056\/NEJMra1510865","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10715_CR49","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y. S., Domm, J., Eustace, B. K., Foell, J., De La Fuente, J., Grupp, S., Handgretinger, R., Ho, T. W., Kattamis, A., Kernytsky, A., Lekstrom-Himes, J., Li, A. M., Locatelli, F., Mapara, M. Y., De Montalembert, M., Rondelli, D., \u2026 Corbacioglu, S. (2021). CRISPR-Cas9 gene editing for sickle cell disease and beta-thalassemia. The New England Journal of Medicine, 384(3), 252\u2013260. https:\/\/doi.org\/10.1056\/NEJMoa2031054","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10715_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K., & Bradley, A. (2018). Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology, 36(8), 765\u2013771. https:\/\/doi.org\/10.1038\/nbt.4192","journal-title":"Nature Biotechnology"},{"key":"10715_CR51","doi-asserted-by":"publisher","unstructured":"Boutin, J., Rosier, J., Cappellen, D., Prat, F., Toutain, J., Pennamen, P., Bouron, J., Rooryck, C., Merlio, J. P., Lamrissi-Garcia, I., Cullot, G., Amintas, S., Guyonnet-Duperat, V., Ged, C., Blouin, J. M., Richard, E., Dabernat, S., Moreau-Gaudry, F., & Bedel, A. (2021). CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. Nature Communications, 12(1). https:\/\/doi.org\/10.1038\/s41467-021-25190-6","DOI":"10.1038\/s41467-021-25190-6"},{"issue":"7866","key":"10715_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","volume":"595","author":"GA Newby","year":"2021","unstructured":"Newby, G. A., Yen, J. S., Woodard, K. J., Mayuranathan, T., Lazzarotto, C. R., Li, Y., Sheppard-Tillman, H., Porter, S. N., Yao, Y., Mayberry, K., Everette, K. A., Jang, Y., Podracky, C. J., Thaman, E., Lechauve, C., Sharma, A., Henderson, J. M., Richter, M. F., Zhao, K. T., \u2026 Liu, D. R. (2021). Base editing of haematopoietic stem cells rescues sickle cell disease in mice. Nature, 595(7866), 295\u2013302. https:\/\/doi.org\/10.1038\/s41586-021-03609-w","journal-title":"Nature"},{"issue":"5","key":"10715_CR53","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41551-023-01026-0","volume":"7","author":"KA Everette","year":"2023","unstructured":"Everette, K. A., Newby, G. A., Levine, R. M., Mayberry, K., Jang, Y., Mayuranathan, T., Nimmagadda, N., Dempsey, E., Li, Y., Bhoopalan, S. V., Liu, X., Davis, J. R., Nelson, A. T., Chen, P. J., Sousa, A. A., Cheng, Y., Tisdale, J. F., Weiss, M. J., Yen, J. S., & Liu, D. R. (2023). Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. Nature Biomedical Engineering, 7(5), 616\u2013628. https:\/\/doi.org\/10.1038\/s41551-023-01026-0","journal-title":"Nature Biomedical Engineering"},{"issue":"2","key":"10715_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","volume":"12","author":"A Cao","year":"2010","unstructured":"Cao, A., & Galanello, R. (2010). Beta-thalassemia. Genetics in Medicine, 12(2), 61\u201376. https:\/\/doi.org\/10.1097\/GIM.0b013e3181cd68ed","journal-title":"Genetics in Medicine"},{"issue":"10116","key":"10715_CR55","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/s0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher, A. T., Weatherall, D. J., & Cappellini, M. D. (2018). Thalassaemia. The Lancet, 391(10116), 155\u2013167. https:\/\/doi.org\/10.1016\/s0140-6736(17)31822-6","journal-title":"The Lancet"},{"issue":"10","key":"10715_CR56","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2022016629","volume":"141","author":"G Hardouin","year":"2023","unstructured":"Hardouin, G., Antoniou, P., Martinucci, P., Felix, T., Manceau, S., Joseph, L., Masson, C., Scaramuzza, S., Ferrari, G., Cavazzana, M., & Miccio, A. (2023). Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) beta-thalassemia mutation. Blood, 141(10), 1169\u20131179. https:\/\/doi.org\/10.1182\/blood.2022016629","journal-title":"Blood"},{"issue":"2","key":"10715_CR57","doi-asserted-by":"publisher","first-page":"E32","DOI":"10.1002\/ajh.26791","volume":"98","author":"P Sebastiani","year":"2022","unstructured":"Sebastiani, P., & Steinberg, M. H. (2022). Fetal hemoglobin per erythrocyte (HbF\/F-cell) after gene therapy for sickle cell anemia. American Journal of Hematology, 98(2), E32\u2013E34. https:\/\/doi.org\/10.1002\/ajh.26791","journal-title":"American Journal of Hematology"},{"issue":"7577","key":"10715_CR58","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., Luc, S., Kurita, R., Nakamura, Y., Fujiwara, Y., Maeda, T., Yuan, G. C., Zhang, F., Orkin, S. H., & Bauer, D. E. (2015). BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature, 527(7577), 192\u2013197. https:\/\/doi.org\/10.1038\/nature15521","journal-title":"Nature"},{"issue":"5","key":"10715_CR59","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-019-0401-y","volume":"25","author":"Y Wu","year":"2019","unstructured":"Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., Shen, A. H., Ren, C., Esrick, E. B., Manis, J. P., Dorfman, D. M., Williams, D. A., Biffi, A., Brugnara, C., Biasco, L., \u2026 Bauer, D. E. (2019). Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nature Medicine, 25(5), 776\u2013783. https:\/\/doi.org\/10.1038\/s41591-019-0401-y","journal-title":"Nature Medicine"},{"issue":"4","key":"10715_CR60","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-020-0790-y","volume":"26","author":"J Zeng","year":"2020","unstructured":"Zeng, J., Wu, Y., Ren, C., Bonanno, J., Shen, A. H., Shea, D., Gehrke, J. M., Clement, K., Luk, K., Yao, Q., Kim, R., Wolfe, S. A., Manis, J. P., Pinello, L., Joung, J. K., & Bauer, D. E. (2020). Therapeutic base editing of human hematopoietic stem cells. Nature Medicine, 26(4), 535\u2013541. https:\/\/doi.org\/10.1038\/s41591-020-0790-y","journal-title":"Nature Medicine"},{"issue":"7","key":"10715_CR61","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","volume":"55","author":"T Mayuranathan","year":"2023","unstructured":"Mayuranathan, T., Newby, G. A., Feng, R., Yao, Y., Mayberry, K. D., Lazzarotto, C. R., Li, Y., Levine, R. M., Nimmagadda, N., Dempsey, E., Kang, G., Porter, S. N., Doerfler, P. A., Zhang, J., Jang, Y., Chen, J., Bell, H. W., Crossley, M., Bhoopalan, S. V., \u2026 Yen, J. S. (2023). Potent and uniform fetal hemoglobin induction via base editing. Nature Genetics, 55(7), 1210\u20131220. https:\/\/doi.org\/10.1038\/s41588-023-01434-7","journal-title":"Nature Genetics"},{"issue":"11","key":"10715_CR62","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1182\/blood-2005-10-4240","volume":"107","author":"T Taniguchi","year":"2006","unstructured":"Taniguchi, T., & D\u2019Andrea, A. D. (2006). Molecular pathogenesis of Fanconi anemia: Recent progress. Blood, 107(11), 4223\u20134233. https:\/\/doi.org\/10.1182\/blood-2005-10-4240","journal-title":"Blood"},{"issue":"1","key":"10715_CR63","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.1038\/s41467-022-34479-z","volume":"13","author":"SM Siegner","year":"2022","unstructured":"Siegner, S. M., Ugalde, L., Clemens, A., Garcia-Garcia, L., Bueren, J. A., Rio, P., Karasu, M. E., & Corn, J. E. (2022). Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells. Nature Communications, 13(1), 6900. https:\/\/doi.org\/10.1038\/s41467-022-34479-z","journal-title":"Nature Communications"},{"issue":"19","key":"10715_CR64","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1056\/NEJMoa031178","volume":"349","author":"HK Dadi","year":"2003","unstructured":"Dadi, H. K., Simon, A. J., & Roifman, C. M. (2003). Effect of CD3delta deficiency on maturation of alpha\/beta and gamma\/delta T-cell lineages in severe combined immunodeficiency. The New England Journal of Medicine, 349(19), 1821\u20131828. https:\/\/doi.org\/10.1056\/NEJMoa031178","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10715_CR65","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","volume":"186","author":"GE McAuley","year":"2023","unstructured":"McAuley, G. E., Yiu, G., Chang, P. C., Newby, G. A., Campo-Fernandez, B., Fitz-Gibbon, S. T., Wu, X., Kang, S. L., Garibay, A., Butler, J., Christian, V., Wong, R. L., Everette, K. A., Azzun, A., Gelfer, H., Seet, C. S., Narendran, A., Murguia-Favela, L., Romero, Z., \u2026 Kohn, D. B. (2023). Human T cell generation is restored in CD3delta severe combined immunodeficiency through adenine base editing. Cell, 186(7), 1398-1416.e23. https:\/\/doi.org\/10.1016\/j.cell.2023.02.027","journal-title":"Cell"},{"issue":"15","key":"10715_CR66","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram, A., Banskota, S., & Liu, D. R. (2022). Therapeutic in vivo delivery of gene editing agents. Cell, 185(15), 2806\u20132827. https:\/\/doi.org\/10.1016\/j.cell.2022.03.045","journal-title":"Cell"},{"issue":"2","key":"10715_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","volume":"4","author":"CS Lee","year":"2017","unstructured":"Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zheng, Z., Shu, Y., Wu, X., Lei, J., Li, Y., Zhang, W., Yang, C., Wu, K., Wu, Y., Ho, S., Athiviraham, A., Lee, M. J., \u2026 He, T. C. (2017). Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes & Diseases, 4(2), 43\u201363. https:\/\/doi.org\/10.1016\/j.gendis.2017.04.001","journal-title":"Genes & Diseases"},{"issue":"5","key":"10715_CR68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2174\/156652321305131212125338","volume":"13","author":"D Cots","year":"2013","unstructured":"Cots, D., Bosch, A., & Chillon, M. (2013). Helper dependent adenovirus vectors: Progress and future prospects. Current Gene Therapy, 13(5), 370\u2013381. https:\/\/doi.org\/10.2174\/156652321305131212125338","journal-title":"Current Gene Therapy"},{"issue":"18","key":"10715_CR69","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","volume":"128","author":"M Richter","year":"2016","unstructured":"Richter, M., Saydaminova, K., Yumul, R., Krishnan, R., Liu, J., Nagy, E. E., Singh, M., Izsvak, Z., Cattaneo, R., Uckert, W., Palmer, D., Ng, P., Haworth, K. G., Kiem, H. P., Ehrhardt, A., Papayannopoulou, T., & Lieber, A. (2016). In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood, 128(18), 2206\u20132217. https:\/\/doi.org\/10.1182\/blood-2016-04-711580","journal-title":"Blood"},{"issue":"6656","key":"10715_CR70","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L., Papp, T. E., Triebwasser, M. P., Yadegari, A., Fedorky, M. T., Tanaka, N., Abdulmalik, O., Pavani, G., Wang, Y., Grupp, S. A., Chou, S. T., Ni, H., Mui, B. L., Tam, Y. K., Weissman, D., Rivella, S., & Parhiz, H. (2023). In vivo hematopoietic stem cell modification by mRNA delivery. Science, 381(6656), 436\u2013443. https:\/\/doi.org\/10.1126\/science.ade6967","journal-title":"Science"},{"issue":"4","key":"10715_CR71","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","volume":"5","author":"C Li","year":"2021","unstructured":"Li, C., Georgakopoulou, A., Mishra, A., Gil, S., Hawkins, R. D., Yannaki, E., & Lieber, A. (2021). In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice. Blood Advances, 5(4), 1122\u20131135. https:\/\/doi.org\/10.1182\/bloodadvances.2020003702","journal-title":"Blood Advances"},{"issue":"19","key":"10715_CR72","doi-asserted-by":"publisher","first-page":"e162939","DOI":"10.1172\/jci.insight.162939","volume":"7","author":"C Li","year":"2022","unstructured":"Li, C., Georgakopoulou, A., Newby, G. A., Everette, K. A., Nizamis, E., Paschoudi, K., Vlachaki, E., Gil, S., Anderson, A. K., Koob, T., Huang, L., Wang, H., Kiem, H. P., Liu, D. R., Yannaki, E., & Lieber, A. (2022). In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. JCI Insight, 7(19), e162939. https:\/\/doi.org\/10.1172\/jci.insight.162939","journal-title":"JCI Insight"},{"issue":"17","key":"10715_CR73","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1182\/blood.2022018252","volume":"141","author":"C Li","year":"2023","unstructured":"Li, C., Georgakopoulou, A., Newby, G. A., Chen, P. J., Everette, K. A., Paschoudi, K., Vlachaki, E., Gil, S., Anderson, A. K., Koob, T., Huang, L., Wang, H., Kiem, H. P., Liu, D. R., Yannaki, E., & Lieber, A. (2023). In vivo HSC prime editing rescues sickle cell disease in a mouse model. Blood, 141(17), 2085\u20132099. https:\/\/doi.org\/10.1182\/blood.2022018252","journal-title":"Blood"},{"issue":"12","key":"10715_CR74","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41577-022-00698-0","volume":"22","author":"CT Charlesworth","year":"2022","unstructured":"Charlesworth, C. T., Hsu, I., Wilkinson, A. C., & Nakauchi, H. (2022). Immunological barriers to haematopoietic stem cell gene therapy. Nature Reviews Immunology, 22(12), 719\u2013733. https:\/\/doi.org\/10.1038\/s41577-022-00698-0","journal-title":"Nature Reviews Immunology"},{"key":"10715_CR75","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-5-13","volume":"5","author":"CL Harteveld","year":"2010","unstructured":"Harteveld, C. L., & Higgs, D. R. (2010). Alpha-thalassaemia. Orphanet Journal of Rare Diseases, 5, 13. https:\/\/doi.org\/10.1186\/1750-1172-5-13","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"1","key":"10715_CR76","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1038\/s41467-021-24402-3","volume":"12","author":"AJ King","year":"2021","unstructured":"King, A. J., Songdej, D., Downes, D. J., Beagrie, R. A., Liu, S., Buckley, M., Hua, P., Suciu, M. C., Oudelaar, A. M., Hanssen, L. L. P., Jeziorska, D., Roberts, N., Carpenter, S. J., Francis, H., Telenius, J., Olijnik, A. A., Sharpe, J. A., Sloane-Stanley, J., Eglinton, J., \u2026 Babbs, C. (2021). Reactivation of a developmentally silenced embryonic globin gene. Nature Communications, 12(1), 4439. https:\/\/doi.org\/10.1038\/s41467-021-24402-3","journal-title":"Nature Communications"},{"issue":"1","key":"10715_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13287-022-02768-5","volume":"13","author":"L Li","year":"2022","unstructured":"Li, L., Yi, H., Liu, Z., Long, P., Pan, T., Huang, Y., Li, Y., Li, Q., & Ma, Y. (2022). Genetic correction of concurrent alpha- and beta-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology. Stem Cell Research & Therapy, 13(1), 102. https:\/\/doi.org\/10.1186\/s13287-022-02768-5","journal-title":"Stem Cell Research & Therapy"},{"issue":"16","key":"10715_CR78","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1182\/blood-2009-10-178129","volume":"115","author":"A Narla","year":"2010","unstructured":"Narla, A., & Ebert, B. L. (2010). Ribosomopathies: Human disorders of ribosome dysfunction. Blood, 115(16), 3196\u20133205. https:\/\/doi.org\/10.1182\/blood-2009-10-178129","journal-title":"Blood"},{"issue":"21","key":"10715_CR79","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1182\/blood.2021011846","volume":"139","author":"MF O'Donohue","year":"2022","unstructured":"O\u2019Donohue, M. F., Da Costa, L., Lezzerini, M., Unal, S., Joret, C., Bartels, M., Brilstra, E., Scheijde-Vermeulen, M., Wacheul, L., De Keersmaecker, K., Vereecke, S., Labarque, V., Saby, M., Lefevre, S. D., Platon, J., Montel-Lehry, N., Laugero, N., Lacazette, E., van Gassen, K., \u2026 MacInnes, A. W. (2022). HEATR3 variants impair nuclear import of uL18 (RPL5) and drive Diamond-Blackfan anemia. Blood, 139(21), 3111\u20133126. https:\/\/doi.org\/10.1182\/blood.2021011846","journal-title":"Blood"},{"issue":"4","key":"10715_CR80","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.bmt.1702784","volume":"27","author":"A Vlachos","year":"2001","unstructured":"Vlachos, A., Federman, N., Reyes-Haley, C., Abramson, J., & Lipton, J. M. (2001). Hematopoietic stem cell transplantation for Diamond Blackfan anemia: A report from the Diamond Blackfan anemia registry. Bone Marrow Transplantation, 27(4), 381\u2013386. https:\/\/doi.org\/10.1038\/sj.bmt.1702784","journal-title":"Bone Marrow Transplantation"},{"key":"10715_CR81","doi-asserted-by":"publisher","first-page":"966084","DOI":"10.3389\/fimmu.2022.966084","volume":"13","author":"A Naseem","year":"2022","unstructured":"Naseem, A., Steinberg, Z., & Cavazza, A. (2022). Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome. Frontiers in Immunology, 13, 966084. https:\/\/doi.org\/10.3389\/fimmu.2022.966084","journal-title":"Frontiers in Immunology"},{"issue":"13","key":"10715_CR82","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin, Y., Mazza, C., Christie, J. R., Giliani, S., Fiorini, M., Mella, P., Gandellini, F., Stewart, D. M., Zhu, Q., Nelson, D. L., Notarangelo, L. D., & Ochs, H. D. (2004). Mutations of the Wiskott-Aldrich syndrome protein (WASP): Hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood, 104(13), 4010\u20134019. https:\/\/doi.org\/10.1182\/blood-2003-05-1592","journal-title":"Blood"},{"issue":"1","key":"10715_CR83","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1038\/s41467-020-17626-2","volume":"11","author":"R Rai","year":"2020","unstructured":"Rai, R., Romito, M., Rivers, E., Turchiano, G., Blattner, G., Vetharoy, W., Ladon, D., Andrieux, G., Zhang, F., Zinicola, M., Leon-Rico, D., Santilli, G., Thrasher, A. J., & Cavazza, A. (2020). Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich syndrome. Nature Communications, 11(1), 4034. https:\/\/doi.org\/10.1038\/s41467-020-17626-2","journal-title":"Nature Communications"},{"key":"10715_CR84","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.0105-2896.2005.00223.x","volume":"203","author":"A Fischer","year":"2005","unstructured":"Fischer, A., Le Deist, F., Hacein-Bey-Abina, S., Andre-Schmutz, I., Basile Gde, S., De Villartay, J. P., & Cavazzana-Calvo, M. (2005). Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunological Reviews, 203, 98\u2013109. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00223.x","journal-title":"Immunological Reviews"},{"key":"10715_CR85","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1182\/blood.V89.6.1968","volume":"89","author":"JM Puck","year":"1997","unstructured":"Puck, J. M., Pepper, A. E., Henthorn, P. S., Candotti, F., Isakov, J., Whitwam, T., Conley, M. E., Fischer, R. E., Rosenblatt, H. M., Small, T. N., & Buckley, R. H. (1997). Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood, 89, 1968\u20131977. https:\/\/doi.org\/10.1182\/blood.V89.6.1968","journal-title":"Blood"},{"key":"10715_CR86","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.omtm.2021.01.001","volume":"20","author":"S Byambaa","year":"2021","unstructured":"Byambaa, S., Uosaki, H., Ohmori, T., Hara, H., Endo, H., Nureki, O., & Hanazono, Y. (2021). Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR\/Cas9. Molecular Therapy Methods & Clinical Development, 20, 451\u2013462. https:\/\/doi.org\/10.1016\/j.omtm.2021.01.001","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"4","key":"10715_CR87","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2174\/156652307781369128","volume":"7","author":"T Moreau","year":"2007","unstructured":"Moreau, T., Calmels, B., Barlogis, V., Michel, G., Tonnelle, C., & Chabannon, C. (2007). Potential application of gene therapy to X-linked agammaglobulinemia. Current Gene Therapy, 7(4), 284\u2013294. https:\/\/doi.org\/10.2174\/156652307781369128","journal-title":"Current Gene Therapy"},{"issue":"3","key":"10715_CR88","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10875-008-9262-8","volume":"29","author":"Y Wang","year":"2009","unstructured":"Wang, Y., Kanegane, H., Wang, X., Han, X., Zhang, Q., Zhao, S., Yu, Y., Wang, J., & Miyawaki, T. (2009). Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China. Journal of Clinical Immunology, 29(3), 352\u2013356. https:\/\/doi.org\/10.1007\/s10875-008-9262-8","journal-title":"Journal of Clinical Immunology"},{"issue":"2","key":"10715_CR89","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., Rose, C., De Villemeur, T. B., & Berger, M. G. (2017). A review of Gaucher disease pathophysiology, clinical presentation and treatments. International Journal of Molecular Sciences, 18(2), 441. https:\/\/doi.org\/10.3390\/ijms18020441","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10715_CR90","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1038\/s41467-020-17148-x","volume":"11","author":"SG Scharenberg","year":"2020","unstructured":"Scharenberg, S. G., Poletto, E., Lucot, K. L., Colella, P., Sheikali, A., Montine, T. J., Porteus, M. H., & Gomez-Ospina, N. (2020). Engineering monocyte\/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing. Nature Communications, 11(1), 3327. https:\/\/doi.org\/10.1038\/s41467-020-17148-x","journal-title":"Nature Communications"},{"issue":"1","key":"10715_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.1380030102","volume":"3","author":"M Horowitz","year":"1994","unstructured":"Horowitz, M., & Zimran, A. (1994). Mutations causing Gaucher disease. Human Mutation, 3(1), 1\u201311. https:\/\/doi.org\/10.1002\/humu.1380030102","journal-title":"Human Mutation"},{"key":"10715_CR92","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.cobme.2023.100480","volume":"28","author":"X Rao","year":"2023","unstructured":"Rao, X., Zhao, H., Shao, C., & Yi, C. (2023). Characterizing off-target effects of genome editors. Current Opinion in Biomedical Engineering, 28, 100480. https:\/\/doi.org\/10.1016\/j.cobme.2023.100480","journal-title":"Current Opinion in Biomedical Engineering"},{"issue":"36","key":"10715_CR93","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/acs.biochem.9b00573","volume":"58","author":"S Park","year":"2019","unstructured":"Park, S., & Beal, P. A. (2019). Off-target editing by CRISPR-guided DNA base editors. Biochemistry, 58(36), 3727\u20133734. https:\/\/doi.org\/10.1021\/acs.biochem.9b00573","journal-title":"Biochemistry"},{"issue":"22","key":"10715_CR94","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1016\/j.cell.2022.09.026","volume":"185","author":"M Pacesa","year":"2022","unstructured":"Pacesa, M., Lin, C. H., Clery, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H., Palermo, G., Cameron, P., Donohoue, P. D., & Jinek, M. (2022). Structural basis for Cas9 off-target activity. Cell, 185(22), 4067-4081.e21. https:\/\/doi.org\/10.1016\/j.cell.2022.09.026","journal-title":"Cell"},{"key":"10715_CR95","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1038\/ncomms15790","volume":"8","author":"HA Rees","year":"2017","unstructured":"Rees, H. A., Komor, A. C., Yeh, W. H., Caetano-Lopes, J., Warman, M., Edge, A. S. B., & Liu, D. R. (2017). Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nature Communications, 8, 15790. https:\/\/doi.org\/10.1038\/ncomms15790","journal-title":"Nature Communications"},{"issue":"1","key":"10715_CR96","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","volume":"9","author":"JK Lee","year":"2018","unstructured":"Lee, J. K., Jeong, E., Lee, J., Jung, M., Shin, E., Kim, Y. H., Lee, K., Jung, I., Kim, D., Kim, S., & Kim, J. S. (2018). Directed evolution of CRISPR-Cas9 to increase its specificity. Nature Communications, 9(1), 3048. https:\/\/doi.org\/10.1038\/s41467-018-05477-x","journal-title":"Nature Communications"},{"issue":"6437","key":"10715_CR97","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.aav9973","volume":"364","author":"E Zuo","year":"2019","unstructured":"Zuo, E., Sun, Y., Wei, W., Yuan, T., Ying, W., Sun, H., Yuan, L., Steinmetz, L. M., Li, Y., & Yang, H. (2019). Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science, 364(6437), 289\u2013292. https:\/\/doi.org\/10.1126\/science.aav9973","journal-title":"Science"},{"issue":"6437","key":"10715_CR98","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.aaw7166","volume":"364","author":"S Jin","year":"2019","unstructured":"Jin, S., Zong, Y., Gao, Q., Zhu, Z. X., Wang, Y. P., Qin, P., Liang, C. Z., Wang, D. W., Qiu, J. L., Zhang, F., & Gao, C. X. (2019). Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice. Science, 364(6437), 292\u2013295. https:\/\/doi.org\/10.1126\/science.aaw7166","journal-title":"Science"},{"issue":"5","key":"10715_CR99","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman, J. L., Raguram, A., Newby, G. A., & Liu, D. R. (2020). Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nature Biotechnology, 38(5), 620\u2013628. https:\/\/doi.org\/10.1038\/s41587-020-0414-6","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10715_CR100","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/s41467-020-15887-5","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Leete, T. C., Born, D. A., Young, L., Barrera, L. A., Lee, S. J., Rees, H. A., Ciaramella, G., & Gaudelli, N. M. (2020). Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. Nature Communications, 11(1), 2052. https:\/\/doi.org\/10.1038\/s41467-020-15887-5","journal-title":"Nature Communications"},{"issue":"20","key":"10715_CR101","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1093\/nar\/gkad855","volume":"51","author":"B Yuan","year":"2023","unstructured":"Yuan, B., Zhang, S., Song, L., Chen, J., Cao, J., Qiu, J., Qiu, Z., Chen, J., Zhao, X. M., & Cheng, T. L. (2023). Engineering of cytosine base editors with DNA damage minimization and editing scope diversification. Nucleic Acids Research, 51(20), e105. https:\/\/doi.org\/10.1093\/nar\/gkad855","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10715_CR102","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41467-023-36004-2","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Song, L., Yuan, B., Zhang, C., Cao, J., Chen, J., Qiu, J., Tai, Y., Chen, J., Qiu, Z., Zhao, X. M., & Cheng, T. L. (2023). TadA reprogramming to generate potent miniature base editors with high precision. Nature Communications, 14(1), 413. https:\/\/doi.org\/10.1038\/s41467-023-36004-2","journal-title":"Nature Communications"},{"issue":"7756","key":"10715_CR103","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","volume":"569","author":"J Gr\u00fcnewald","year":"2019","unstructured":"Gr\u00fcnewald, J., Zhou, R., Garcia, S. P., Iyer, S., Lareau, C. A., Aryee, M. J., & Joung, J. K. (2019). Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature, 569(7756), 433\u2013437. https:\/\/doi.org\/10.1038\/s41586-019-1161-z","journal-title":"Nature"},{"issue":"9","key":"10715_CR104","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41587-019-0236-6","volume":"37","author":"J Grunewald","year":"2019","unstructured":"Grunewald, J., Zhou, R., Iyer, S., Lareau, C. A., Garcia, S. P., Aryee, M. J., & Joung, J. K. (2019). CRISPR DNA base editors with reduced RNA off-target and self-editing activities. Nature Biotechnology, 37(9), 1041\u20131048. https:\/\/doi.org\/10.1038\/s41587-019-0236-6","journal-title":"Nature Biotechnology"},{"key":"10715_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01915-4","author":"M Fiumara","year":"2023","unstructured":"Fiumara, M., Ferrari, S., Omer-Javed, A., Beretta, S., Albano, L., Canarutto, D., Varesi, A., Gaddoni, C., Brombin, C., Cugnata, F., Zonari, E., Naldini, M. M., Barcella, M., Gentner, B., Merelli, I., & Naldini, L. (2023). Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-023-01915-4","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10715_CR106","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41467-023-37508-7","volume":"14","author":"N Yan","year":"2023","unstructured":"Yan, N., Feng, H., Sun, Y., Xin, Y., Zhang, H., Lu, H., Zheng, J., He, C., Zuo, Z., Yuan, T., Li, N., Xie, L., Wei, W., Sun, Y., & Zuo, E. (2023). Cytosine base editors induce off-target mutations and adverse phenotypic effects in transgenic mice. Nature Communications, 14(1), 1784. https:\/\/doi.org\/10.1038\/s41467-023-37508-7","journal-title":"Nature Communications"},{"issue":"12","key":"10715_CR107","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.stem.2023.10.007","volume":"30","author":"W Han","year":"2023","unstructured":"Han, W., Qiu, H. Y., Sun, S., Fu, Z. C., Wang, G. Q., Qian, X., Wang, L., Zhai, X., Wei, J., Wang, Y., Guo, Y. L., Cao, G. H., Ji, R. J., Zhang, Y. Z., Ma, H., Wang, H., Zhao, M., Wu, J., Bi, L., \u2026 Zhang, Y. (2023). Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs. Cell Stem Cell, 30(12), 1624-1639 e8. https:\/\/doi.org\/10.1016\/j.stem.2023.10.007","journal-title":"Cell Stem Cell"},{"issue":"6488","key":"10715_CR108","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N., & Kleinstiver, B. P. (2020). Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science, 368(6488), 290\u2013296. https:\/\/doi.org\/10.1126\/science.aba8853","journal-title":"Science"},{"issue":"10","key":"10715_CR109","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nbt.4199","volume":"36","author":"JM Gehrke","year":"2018","unstructured":"Gehrke, J. M., Cervantes, O., Clement, M. K., Wu, Y., Zeng, J., Bauer, D. E., Pinello, L., & Joung, J. K. (2018). An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities. Nature Biotechnology, 36(10), 977\u2013982. https:\/\/doi.org\/10.1038\/nbt.4199","journal-title":"Nature Biotechnology"},{"issue":"7","key":"10715_CR110","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.stem.2023.06.002","volume":"30","author":"HJ Becker","year":"2023","unstructured":"Becker, H. J., Ishida, R., Wilkinson, A. C., Kimura, T., Lee, M. S. J., Coban, C., Ota, Y., Tanaka, Y., Roskamp, M., Sano, T., Tojo, A., Kent, D. G., & Yamazaki, S. (2023). Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion. Cell Stem Cell, 30(7), 987-1000 e8. https:\/\/doi.org\/10.1016\/j.stem.2023.06.002","journal-title":"Cell Stem Cell"},{"key":"10715_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01821-9","author":"L Chen","year":"2023","unstructured":"Chen, L., Hong, M., Luan, C., Gao, H., Ru, G., Guo, X., Zhang, D., Zhang, S., Li, C., Wu, J., Randolph, P. B., Sousa, A. A., Qu, C., Zhu, Y., Guan, Y., Wang, L., Liu, M., Feng, B., Song, G., \u2026 Li, D. (2023). Adenine transversion editors enable precise, efficient A*T-to-C*G base editing in mammalian cells and embryos. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-023-01821-9","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10715_CR112","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1038\/s41467-021-25217-y","volume":"12","author":"T Yuan","year":"2021","unstructured":"Yuan, T., Yan, N., Fei, T., Zheng, J., Meng, J., Li, N., Liu, J., Zhang, H., Xie, L., Ying, W., Li, D., Shi, L., Sun, Y., Li, Y., Li, Y., Sun, Y., & Zuo, E. (2021). Optimization of C-to-G base editors with sequence context preference predictable by machine learning methods. Nature Communications, 12(1), 4902. https:\/\/doi.org\/10.1038\/s41467-021-25217-y","journal-title":"Nature Communications"},{"issue":"1","key":"10715_CR113","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1038\/s41467-021-25375-z","volume":"12","author":"KF Marquart","year":"2021","unstructured":"Marquart, K. F., Allam, A., Janjuha, S., Sintsova, A., Villiger, L., Frey, N., Krauthammer, M., & Schwank, G. (2021). Predicting base editing outcomes with an attention-based deep learning algorithm trained on high-throughput target library screens. Nature Communications, 12(1), 5114. https:\/\/doi.org\/10.1038\/s41467-021-25375-z","journal-title":"Nature Communications"},{"key":"10715_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01792-x","author":"N Kim","year":"2023","unstructured":"Kim, N., Choi, S., Kim, S., Song, M., Seo, J. H., Min, S., Park, J., Cho, S. R., & Kim, H. H. (2023). Deep learning models to predict the editing efficiencies and outcomes of diverse base editors. Nature Biotechnology. https:\/\/doi.org\/10.1038\/s41587-023-01792-x","journal-title":"Nature Biotechnology"},{"issue":"1","key":"10715_CR115","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1038\/s41467-023-41004-3","volume":"14","author":"C Zhang","year":"2023","unstructured":"Zhang, C., Yang, Y., Qi, T., Zhang, Y., Hou, L., Wei, J., Yang, J., Shi, L., Ong, S. G., Wang, H., Wang, H., Yu, B., & Wang, Y. (2023). Prediction of base editor off-targets by deep learning. Nature Communications, 14(1), 5358. https:\/\/doi.org\/10.1038\/s41467-023-41004-3","journal-title":"Nature Communications"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10715-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10715-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T06:21:59Z","timestamp":1723443719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10715-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10715"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10715-5","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"25 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the authors provided consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}